U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry UNKNOWN
Molecular Formula C11H18N2O
Molecular Weight 194.2734
Optical Activity ( - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PRISOTINOL, (-)-

SMILES

CC(C)NC(C)CC1=CC=C(O)C=N1

InChI

InChIKey=WQRPBKUCJBWQRT-UHFFFAOYSA-N
InChI=1S/C11H18N2O/c1-8(2)13-9(3)6-10-4-5-11(14)7-12-10/h4-5,7-9,13-14H,6H2,1-3H3

HIDE SMILES / InChI

Description

Prisotinol is aminoalkyl-5-pyridinol patented by Ciba-Geigy A.-G. for treatment of angina pectoris. Prisotinol was studied in phase II clinical trials as a cardioprotective agent.

Originator

Ciba-Geigy A.-G.
15
Sources: JP 55149260; 2-​Aminoalkyl-​5-​pyridinols; Nov 20, 1980

Approval Year

Unknown
149124
PubMed

PubMed

TitleDatePubMed
Urinary excretion of CGS 5,649 and its conjugated glucuronide and sulfate in man.
1991
Patents

Patents

20070122474
47
JP55149260
6

Sample Use Guides

In Vivo Use Guide
90, 200, or 600 mg
Route of Administration: Oral
Name Type Language
3-PYRIDINOL, 6-(2-((1-METHYLETHYL)AMINO)PROPYL)-, (-)-
Preferred Name English
PRISOTINOL, (-)-
Common Name English
(-)-6-(2-((1-METHYLETHYL)AMINO)PROPYL)-3-PYRIDINOL
Common Name English
Code System Code Type Description
CAS
78152-30-4
Created by admin on Mon Mar 31 23:14:40 GMT 2025 , Edited by admin on Mon Mar 31 23:14:40 GMT 2025
PRIMARY
FDA UNII
Z7JEE5QDD2
Created by admin on Mon Mar 31 23:14:40 GMT 2025 , Edited by admin on Mon Mar 31 23:14:40 GMT 2025
PRIMARY
SUBSTANCE RECORD
Structure of PRISOTINOL, (-)-
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966